Bridget Martell

Dr. Bridget A. Martell, MD, is an Independent Director at Delcath Systems, Inc., a Senior Biopharmaceutical Advisor at Two Bear Capital Operations LLC, an Independent Director at Aligos Therapeutics, Inc. and an Independent Director at Achieve Life Sciences, Inc. She is on the Board of Directors at Delcath Systems, Inc., Aligos Therapeutics, Inc. and Achieve Life Sciences, Inc. Dr. Martell was previously employed as an Independent Director by POINT Biopharma Global, Inc., a President & Chief Executive Officer by Artizan Biosciences, Inc., a Partner by AlleyCorp LLC, a Chief Medical Officer by Verseau Therapeutics, Inc., a Chief Medical Officer by Nobias Therapeutics, Inc., a Chief Medical Officer by RRD International LLC, a Chief Medical Officer by Kura Oncology, Inc., a Chief Medical Officer by Juniper Pharmaceuticals, Inc., an Executive Director & Head-Medical Affairs by Purdue Pharma LP, a Medical Director by Albert Einstein College of Medicine, Inc., a Professor by Yale-New Haven Hospital, Inc., a Managing Director by Bam Consultants Ltd., and a Chief Resident by Yale School of Medicine.
She also served on the board at Ayala Pharmaceuticals, Inc. She received her undergraduate degree from Cornell University, a graduate degree from Boston University School of Medicine and a doctorate degree from Rosalind Franklin University of Medicine & Science.